abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of bcl-6. The compositions comprise antisense coumpounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-6. Methods of using these compounds for modulation of bcl-6 expression and for treatment of diseases associated with expression of bcl-6 are provided. |